COVID-19 spike variants antigen Recombinant 2019-nCoV(SARS-CoV-2) Spike Protein RBD D364Y mutant (S RBD D364Y,C-HisTag)
Cat No.: GMP-V-2019nCoV-Smu-007
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Package||Catalog No.||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Host specics||2019-nCoV(SARS-CoV-2, SARS2-coronavirus)|
|Source (Expression Host)||Mamamlian (human cell)|
|Products description||Recombinant 2019-nCoV(SARS-CoV-2) receptor binding domain (RBD) from the Spike Protein (S protein) with D364Y mutation was expressed in mammanlian cell (human cells) expression system. The target gene encoding Arg319-Phe541(D364Y) was expressed with 6 HIS tag at the C-terminus.|
|Bioactivity validation|| ACE2 binding; |
Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays;
|Purity||Purity: ≥95% (SDS-PAGE)|
|Application||Spike protein & ACE2 competition binding assay for efficacy evaluation of COVID-19 vaccines and therapeutic antibodies.|
Immunogen in Elisa,lateral-flow tests,and other immunoassays;
The antigen can also be used in drug discovery including antibody screening and lead compound candidates assay.
|predicted Molecular Mass||26kDa|
|Formulation||Lyophilized from sterile PBS, PH 7.4|
|Storage||Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.|
COVID-19 recombinant SARS-CoV2 (2019 nCoV coronavirus) antigen:
Spike Protein RBD D364Y mutant (S RBD D364Y,C-HisTag)
Suitable for variants of Spike protein & ACE2 competition binding assay for efficacy evaluation of COVID-19vaccines and therapeutic antibodies.